Developer docs
API playgroundTry for free, no card

Search company profiles

B Positive Plasma

Full company profile

uuid0025kog

Namestring
B Positive Plasma
Legal namestring
B Positive Plasma LLC
Company typeenum
Private
Founded yearint
2010
Descriptiontext

B Positive Plasma is a privately held plasma collection company that operates physical donation centers where individual donors sell plasma that is subsequently processed by biopharmaceutical manufacturers into life-saving therapies for rare and chronic conditions including Primary Immune Deficiency, Alpha-1, and Hemophilia. Founded in 2010 and headquartered in Cherry Hill, New Jersey, the company is structured as B Positive Plasma LLC and operates as a subsidiary of B Positive National Blood Services. As of the available data, it runs 11-12 donation centers across Pennsylvania (Cheltenham, Bethlehem, City Ave/Merion Station, Easton, Holmes, Scranton, Edwardsville/Wilkes-Barre, Wyoming), New Jersey (Atlantic City, Bloomfield, Egg Harbor Township), and Delaware (Wilmington), with an additional walk-in-capable site at Aramingo Avenue in Philadelphia referenced in operational communications.

The company's core technology is standard plasmapheresis equipment that separates plasma from blood components and returns red blood cells to the donor via the same needle, enabling donors to give up to twice per week. Its product platform is unified around a donor-centric service model: donors schedule appointments online, complete a brief medical screening, donate (taking approximately 90 minutes), and receive compensation through a proprietary B Positive Visa Debit Card issued at first donation. Supporting programs include the New Donor Rewards Program (over $800 in first-month earnings for new donors, up to $135 weekly thereafter) and a Refer a Friend program paying $10 per successful referral.

B Positive Plasma generates revenue by collecting plasma and supplying it to the biopharmaceutical industry under a transaction-fee model, while paying donors usage-based compensation that varies by location, donor tenure, and promotional period. Its primary customer segment is middle-class Americans seeking supplemental income to cover expenses such as rent, medical bills, and childcare, though it explicitly accepts donors of all blood types despite the company name. The company competes in the U.S. plasma collection market — an industry that generates $4.7 billion in annual payments, supplies approximately 70% of the world's plasma, and has seen a 30% increase in collections since 2022 — against larger national operators including CSL Plasma, BioLife, and Grifols.

Short descriptiontext

B Positive Plasma is a privately held plasma collection company operating 11-12 donation centers across Pennsylvania, New Jersey, and Delaware. It supplies plasma to biopharmaceutical manufacturers for life-saving therapies while compensating individual donors via a proprietary Visa debit card and rewards program.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersHaddonfield, United States
HQ citystring
Haddonfield
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices12 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
plasma collection services, blood plasma donation, plasmapheresis services, plasma donation centers, donor compensation programs
Industry4 codes
PRIMARYHLAIAHAH
Plasma Collection & Donor Services (Plasmapheresis Centers)
SECONDARYHLAAAAAI
Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors)
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYHLAIAHAL
Plasma-Derived Therapy Cold Chain & Specialty Logistics
SECONDARYBPAGACAJ
Blood, Organ & Tissue Donation Organizations
NAICS code1 code
  • Blood and Organ Banks621991
SIC code1 code
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Blood Plasma Collection Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Plasma Collection and Sale
TypeTransaction Fee
Description

B Positive Plasma collects plasma from donors at its collection centers. The plasma is processed by biopharmaceutical companies into life-saving medicines and treatments that are exported globally. The company generates revenue by supplying plasma to the medical/pharmaceutical industry.

nbcnews.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales
Pricing details3 tiers
1New Donor First Month Earning Potential
ModelUsage-basedBilling cadenceMonthly
Notes

First-time (new) donors can earn over $800 in their first month of donations.

bpositiveplasma.com
2Regular Repeat Donor Weekly Earning Potential
ModelUsage-basedBilling cadenceWeekly
Notes

Regular, repeat donors can earn up to $135 per week. Qualified donors are eligible to donate up to twice a week (with at least one calendar day between donations).

bpositiveplasma.com
3Referral Bonus
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Successfully referring donors to B Positive earns $10 per referral, paid to the donor's B Positive Visa Debit card.

bpositiveplasma.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

B Positive Plasma operates physical plasma donation centers across Pennsylvania, New Jersey, and Delaware where individual donors undergo plasmapheresis procedures to supply source plasma. The collected plasma is provided to biopharmaceutical manufacturers for fractionation into life-saving vaccines and therapies for rare and chronic diseases. Donors are compensated for their time via a reloadable B Positive Visa Debit card, with new donors eligible for $800+ in their first month and regular donors able to earn up to $135 per week.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 130 donations needed to treat one patient with Primary Immune Deficiency for one year
+2 more records
Product overview1 text field

B Positive Plasma operates a unified plasma donation service platform comprising 11 collection centers across Pennsylvania, New Jersey, and Delaware. The core offering is plasma collection with donor compensation via the B Positive Visa Debit Card. Supporting offerings include the New Donor Rewards Program providing new donors over $800 in their first month and regular donors up to $135 weekly, plus the Refer a Friend Program paying $10 per referral. Donors can donate plasma up to twice weekly with visits taking approximately 90 minutes. The company positions itself as a donor-focused service contributing plasma to biopharmaceutical companies for life-saving treatments and vaccines.

Product and service2 records
1Plasma Donation Service
CategoryPlasma Collection Service
Description

Core service in which individual donors visit a B Positive Plasma donation center in PA, NJ, or DE and undergo plasmapheresis to supply blood plasma. The collected plasma is provided to biopharmaceutical manufacturers for fractionation into vaccines and therapies for rare and chronic diseases. Open to donors of all blood types with new donor compensation of $800+ in the first month and up to $135 per week for regular donors.

2B Positive Visa Debit Card
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1B Positive National Blood Services
Strategic tierCoreTypeOthers
Description

B Positive Plasma operates as a B Positive National Blood Services company, indicating it is part of a national network of blood services organizations.

bpositiveplasma.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Haemonetics
TypeOthers
Description

Supplier of plasmapheresis equipment and blood component collection technology used across the plasma industry. Not a collector, but its products are core to B Positive's operating model and its commercial performance signals industry-wide collection trends.

2Versiti
TypeBroad incumbent
Description

Large nonprofit blood and plasma collector operating across multiple states. Comparable donor collection operations and regulatory framework, though nonprofit-driven rather than for-profit; relevant for understanding institutional buyer-supplier dynamics.

TypeDirect peer
Description

Privately held US plasma collection company operating 30+ centers. Closest size comp to B Positive as an independent, multi-center collector without vertical fractionation integration.

TypeDirect peer
Description

Plasma collection arm of Grifols, one of the three global fractionators, operating 100+ US centers. Directly comparable business model and regulatory regime; competes for the same donor pool and operates its own fractionation downstream.

TypeDirect peer
Description

Plasma collection subsidiary of ADMA Biologics, operating FDA-licensed centers that supply raw plasma for its proprietary immune globulin products. Comparable regulated plasma collection operations and donor-driven GTM.

TypeDirect peer
Description

Subsidiary of Takeda Pharmaceutical, operating ~140 plasma donation centers across the US. Comparable donor compensation model, FDA-regulated plasmapheresis operations, and direct competitor for both donors and downstream fractionation buyers.

TypeEmerging player
Description

Smaller US plasma and blood products collector. Comparable center-based collection model but smaller scale; provides a peer benchmark for sub-scale operators in the same industry.

TypeDirect peer
Description

Subsidiary of CSL Behring and the world's largest plasma collection network with 300+ US centers. Directly comparable as a for-profit plasma collection business selling raw plasma to a vertically integrated fractionator; same donor model, same regulatory framework.

TypeDirect peer
Description

US plasma collection subsidiary of Octapharma AG, operating 90+ centers. Same for-profit collection model, same donor compensation structure, and competes with B Positive for donors in overlapping geographies.

TypeDirect peer
Description

US plasma collection operations of Kedrion Biopharma. Comparable for-profit plasma collection business model with center-based donor acquisition and similar regulatory and operational footprint.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

B Positive Plasma

Blood Plasma Collection Servicesbpositivetoday.com

B Positive Plasma is a privately held plasma collection company operating 11-12 donation centers across Pennsylvania, New Jersey, and Delaware. It supplies plasma to biopharmaceutical manufacturers for life-saving therapies while compensating individual donors via a proprietary Visa debit card and rewards program.

What B Positive Plasma does

B Positive Plasma is a privately held plasma collection company that operates physical donation centers where individual donors sell plasma that is subsequently processed by biopharmaceutical manufacturers into life-saving therapies for rare and chronic conditions including Primary Immune Deficiency, Alpha-1, and Hemophilia. Founded in 2010 and headquartered in Cherry Hill, New Jersey, the company is structured as B Positive Plasma LLC and operates as a subsidiary of B Positive National Blood Services. As of the available data, it runs 11-12 donation centers across Pennsylvania (Cheltenham, Bethlehem, City Ave/Merion Station, Easton, Holmes, Scranton, Edwardsville/Wilkes-Barre, Wyoming), New Jersey (Atlantic City, Bloomfield, Egg Harbor Township), and Delaware (Wilmington), with an additional walk-in-capable site at Aramingo Avenue in Philadelphia referenced in operational communications.

The company's core technology is standard plasmapheresis equipment that separates plasma from blood components and returns red blood cells to the donor via the same needle, enabling donors to give up to twice per week. Its product platform is unified around a donor-centric service model: donors schedule appointments online, complete a brief medical screening, donate (taking approximately 90 minutes), and receive compensation through a proprietary B Positive Visa Debit Card issued at first donation. Supporting programs include the New Donor Rewards Program (over $800 in first-month earnings for new donors, up to $135 weekly thereafter) and a Refer a Friend program paying $10 per successful referral.

B Positive Plasma generates revenue by collecting plasma and supplying it to the biopharmaceutical industry under a transaction-fee model, while paying donors usage-based compensation that varies by location, donor tenure, and promotional period. Its primary customer segment is middle-class Americans seeking supplemental income to cover expenses such as rent, medical bills, and childcare, though it explicitly accepts donors of all blood types despite the company name. The company competes in the U.S. plasma collection market — an industry that generates $4.7 billion in annual payments, supplies approximately 70% of the world's plasma, and has seen a 30% increase in collections since 2022 — against larger national operators including CSL Plasma, BioLife, and Grifols.

B Positive Plasma firmographics

Firmographics
Name
B Positive Plasma
Legal name
B Positive Plasma LLC
Website
https://bpositivetoday.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
51–100 employees
Short description
B Positive Plasma is a privately held plasma collection company operating 11-12 donation centers across Pennsylvania, New Jersey, and Delaware. It supplies plasma to biopharmaceutical manufacturers for life-saving therapies while compensating individual donors via a proprietary Visa debit card and rewards program.
Ownership category
akta.pro rank

B Positive Plasma industry classification

Industry
Product category
Blood Plasma Collection Services
NAICS
Blood and Organ Banks (621991)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAIAHAH
Plasma Collection & Donor Services (Plasmapheresis Centers)
SECONDARYHLAAAAAI
Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors)
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYHLAIAHAL
Plasma-Derived Therapy Cold Chain & Specialty Logistics
SECONDARYBPAGACAJ
Blood, Organ & Tissue Donation Organizations

Keywords

  • Plasma collection services
  • Blood plasma donation
  • Plasmapheresis services
  • Plasma donation centers
  • Donor compensation programs

Where B Positive Plasma is headquartered

Location

Headquarters

HQ city
Haddonfield
HQ country
United States
HQ region
North America

Offices12 records

Markets served

B Positive Plasma business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

  1. Plasma Collection and Sale: B Positive Plasma collects plasma from donors at its collection centers. The plasma is processed by biopharmaceutical companies into life-saving medicines and treatments that are exported globally. The company generates revenue by supplying plasma to the medical/pharmaceutical industry.

Pricing tiers

ModelBillingPrice
Usage-basedMonthlyNew Donor First Month Earning Potential
Usage-basedWeeklyRegular Repeat Donor Weekly Earning Potential
Transaction based/ take ratePay-as-you-goReferral Bonus

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

B Positive Plasma product offering

Product offering

Core offering

B Positive Plasma operates physical plasma donation centers across Pennsylvania, New Jersey, and Delaware where individual donors undergo plasmapheresis procedures to supply source plasma. The collected plasma is provided to biopharmaceutical manufacturers for fractionation into life-saving vaccines and therapies for rare and chronic diseases. Donors are compensated for their time via a reloadable B Positive Visa Debit card, with new donors eligible for $800+ in their first month and regular donors able to earn up to $135 per week.

Product overview

B Positive Plasma operates a unified plasma donation service platform comprising 11 collection centers across Pennsylvania, New Jersey, and Delaware. The core offering is plasma collection with donor compensation via the B Positive Visa Debit Card. Supporting offerings include the New Donor Rewards Program providing new donors over $800 in their first month and regular donors up to $135 weekly, plus the Refer a Friend Program paying $10 per referral. Donors can donate plasma up to twice weekly with visits taking approximately 90 minutes. The company positions itself as a donor-focused service contributing plasma to biopharmaceutical companies for life-saving treatments and vaccines.

Differentiator

Problem solved

Functional benefit

Products and services

  • Plasma Donation Service Core service in which individual donors visit a B Positive Plasma donation center in PA, NJ, or DE and undergo plasmapheresis to supply blood plasma. The collected plasma is provided to biopharmaceutical manufacturers for fractionation into vaccines and therapies for rare and chronic diseases. Open to donors of all blood types with new donor compensation of $800+ in the first month and up to $135 per week for regular donors.
  • B Positive Visa Debit Card

Quantifiable outcome

  • 130 donations needed to treat one patient with Primary Immune Deficiency for one year
  • +2 more outcomes

Companies that use B Positive Plasma

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

B Positive Plasma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

B Positive Plasma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • B Positive National Blood ServicescoreOthersB Positive Plasma operates as a B Positive National Blood Services company, indicating it is part of a national network of blood services organizations.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

B Positive Plasma competitors and assessment

Company assessment

Others

  • Haemonetics: Supplier of plasmapheresis equipment and blood component collection technology used across the plasma industry. Not a collector, but its products are core to B Positive's operating model and its commercial performance signals industry-wide collection trends.

Broad incumbents

  • Versiti: Large nonprofit blood and plasma collector operating across multiple states. Comparable donor collection operations and regulatory framework, though nonprofit-driven rather than for-profit; relevant for understanding institutional buyer-supplier dynamics.

Direct peers

  • ImmunoTek Bio Centers: Privately held US plasma collection company operating 30+ centers. Closest size comp to B Positive as an independent, multi-center collector without vertical fractionation integration.
  • Grifols Plasma: Plasma collection arm of Grifols, one of the three global fractionators, operating 100+ US centers. Directly comparable business model and regulatory regime; competes for the same donor pool and operates its own fractionation downstream.
  • ADMA BioCenters: Plasma collection subsidiary of ADMA Biologics, operating FDA-licensed centers that supply raw plasma for its proprietary immune globulin products. Comparable regulated plasma collection operations and donor-driven GTM.
  • BioLife Plasma Services: Subsidiary of Takeda Pharmaceutical, operating ~140 plasma donation centers across the US. Comparable donor compensation model, FDA-regulated plasmapheresis operations, and direct competitor for both donors and downstream fractionation buyers.
  • CSL Plasma: Subsidiary of CSL Behring and the world's largest plasma collection network with 300+ US centers. Directly comparable as a for-profit plasma collection business selling raw plasma to a vertically integrated fractionator; same donor model, same regulatory framework.
  • Octapharma Plasma: US plasma collection subsidiary of Octapharma AG, operating 90+ centers. Same for-profit collection model, same donor compensation structure, and competes with B Positive for donors in overlapping geographies.
  • Kedrion Biopharma (KEDPlasma): US plasma collection operations of Kedrion Biopharma. Comparable for-profit plasma collection business model with center-based donor acquisition and similar regulatory and operational footprint.

Emerging players

  • Interstate Blood Bank (IBBI): Smaller US plasma and blood products collector. Comparable center-based collection model but smaller scale; provides a peer benchmark for sub-scale operators in the same industry.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

B Positive Plasma social profiles

Digital presence

B Positive Plasma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

B Positive Plasma leadership team

Management profile

Number of profiles

Profiles1 record

B Positive Plasma funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

B Positive Plasma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about B Positive Plasma

What does B Positive Plasma do?

B Positive Plasma operates physical plasma donation centers across Pennsylvania, New Jersey, and Delaware where individual donors undergo plasmapheresis procedures to supply source plasma. The collected plasma is provided to biopharmaceutical manufacturers for fractionation into life-saving vaccines and therapies for rare and chronic diseases. Donors are compensated for their time via a reloadable B Positive Visa Debit card, with new donors eligible for $800+ in their first month and regular donors able to earn up to $135 per week.

Is B Positive Plasma a public or private company?

B Positive Plasma is a private company. It is classified as corporate owned and is currently operating.

When was B Positive Plasma founded?

B Positive Plasma was founded in 2010. It employs 51 to 100 people.

Where is B Positive Plasma based?

B Positive Plasma is headquartered in Haddonfield, United States, in the North America region.

How does B Positive Plasma make money?

One revenue line is on record: plasma Collection and Sale.

Who are B Positive Plasma's main competitors?

Haemonetics is listed as an others. Versiti is listed as a broad incumbent. Direct peers are ImmunoTek Bio Centers, Grifols Plasma, ADMA BioCenters, BioLife Plasma Services, CSL Plasma, Octapharma Plasma and Kedrion Biopharma (KEDPlasma). Interstate Blood Bank (IBBI) is listed as an emerging player.

Does B Positive Plasma have an API?

No public API is recorded for B Positive Plasma.

What industry is B Positive Plasma in?

B Positive Plasma's product category is Blood Plasma Collection Services. Its primary akta.pro industry code is HLAIAHAH, Plasma Collection & Donor Services (Plasmapheresis Centers), with a secondary code of HLAAAAAI, Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors). Its NAICS code is 621991 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals